The market environment was particularly challenging due to tariffs. We shifted production from China to other locations, including Malaysia, Thailand, Vietnam, Egypt and our own factories.
— Walter C. Johnsen, Chairman and CEO
03Detailed Report
ACU
Company ACU
Period
Q2 2025
CurrencyUSD
Report TypeQuarterly Earnings
GeneratedJun 18, 2026
Swipe to view all report sections
Executive Summary
Acme United delivered a resilient QQ2 2025 performance despite meaningful tariff headwinds. Net sales declined 3% year over year to $54.0 million, while net income rose to $4.8 million and diluted EPS reached $1.16, marking a quarterly earnings record when excluding legacy onetime items. The gross margin stood at 41.0%, with operating margin at 11.8% and net margin at 8.8%. Management attributes the top-line softness primarily to 145% tariffs on Chinese imports, which disrupted Westcott (cutting tools) and to a lesser extent other segments, prompting customers to delay or cancel orders. Acme responded with price discipline, cost reduction, and accelerated localization of production. The company continues to invest for capacity and efficiency gains, including the Mount Pleasant Spill Magic facility acquisition ( ~$6 million ), expanded Med‑Nap operations in Florida, and automation upgrades across multiple plants. Management remains confident in growth in the second half of 2025, with anticipated sequential growth in Q3 and Q4 driven by recovery of delayed programs and share gains in Westcott and First Aid products. Net debt declined meaningfully to about $30.7 million (vs. ~$33 million a year prior), while free cash flow for the trailing twelve months was around $12 million, supporting an unchanged or increasing dividend and ongoing buy‑back capacity if pursued. The company also signaled ongoing supply‑chain diversification, including shifting production away from China to Malaysia, Thailand, Vietnam, Egypt, and internal facilities, to better navigate tariff risk and strengthen service levels.
Key Performance Indicators
Revenue
Decreasing
54.00M
QoQ: 17.49% | YoY: -2.58%
Gross Profit
Decreasing
22.15M
41.02% margin
QoQ: 23.62% | YoY: -2.11%
Operating Income
Increasing
6.39M
QoQ: 163.40% | YoY: 0.24%
Net Income
Increasing
4.75M
QoQ: 187.48% | YoY: 6.74%
EPS
Increasing
1.26
QoQ: 186.36% | YoY: 4.13%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue: $54.0m in Q2 2025, down 2.58% YoY and up 17.49% QoQ per reported metrics; Gross Profit: $21.149m, gross margin 41.02% (YoY margin ~41.0%, 6‑month margin 40%), Operating Income: $6.39m, operating margin 11.83% (QoQ surge driven by cost controls and mix); Net Income: $4.75m, net margin 8.80% (YoY up 6.74%, QoQ up 187.48%); EPS (diluted): $1.16; EPS (GAAP): $1.26; EBITDA: $8.041m; EBITDARatio: 14.89%; SG&A: $15.76m in Q2 (29% of sales); 6‑month SG&A: $31.3m (31% of sales); Balance Sheet: Total assets $171.15m; Total debt $34.39m; Net debt $30.75m; Cash & equivalents $3.64m; Equity $113.72m; Liquidity: current ratio 4.32, quick ratio 1.88, cash ratio 0.16; Cash flow snapshot (TTM): free cash flow ~$12m; DSO ~60.3 days, DIO ~162 days, DPO ~28.8 days (CCC ~222 days); Cash flow indicators imply solid operating cash generation and gradual deleveraging. Valuation: P/E ~8.2x, P/B ~1.38x, P/S ~2.90x, dividend yield ~0.39%.
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
54.00M
-2.58%
17.49%
Gross Profit
22.15M
-2.11%
23.62%
Operating Income
6.39M
0.24%
163.40%
Net Income
4.75M
6.74%
187.48%
EPS
1.26
4.13%
186.36%
Key Financial Ratios
Gross Profit Margin
Good
41.00%
Gross profit margin is healthy and competitive within industry standards
Operating Profit Margin
Fair
11.80%
Operating margin is moderate, room for improvement in cost management
Net Profit Margin
Fair
8.80%
Net profit margin is moderate, room for improvement in cost management
Return on Assets
Weak
2.78%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
4.18%
Return on equity suggests inefficient capital allocation
Current Ratio
Strong
4.32
Current ratio indicates excellent liquidity and financial flexibility
Debt to Equity
Conservative
0.30
Debt-to-equity shows conservative leverage and low financial risk
P/E Ratio
Value
8.23x
P/E ratio suggests potential undervaluation or stable earnings
Price to Book
Fair Value
1.38x
Price-to-book ratio reasonable for profitable companies
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.
Acme United Corporation (ACU) QQ1 2025 Results — Steady Core Growth with Tariff Volatility, North American Acquisitions optionality, and Automation-...
Acme United Corporation (ACU) QQ4 2024 Earnings Analysis: Record EBITDA and Margin Expansion Amid Tariff Readiness in a Diversified Safety and First A...
Edgewell Personal Care Company (EPC) QQ2 2025 Earnings Review: International Momentum, North American Transformation, Tariff Headwinds, and 2025 Outlo...